Zhiyong Q. Li

Guangzhou Dadao Bei Street
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Clinical, surgical, and molecular characteristics and outcomes of adult patients with diffuse midline glioma, H3 K27-altered, treated with surgical resection.

Clinical, surgical, and molecular characteristics and outcomes of adult patients with diffuse midline glioma, H3 K27-altered, treated with surgical resection.

Journal: Journal of neuro-oncology

Published: May 17, 2026

Contemporary Precision Stratification and Prognostic Features of Primary Gliomas in a Southern Chinese Population.

Contemporary Precision Stratification and Prognostic Features of Primary Gliomas in a Southern Chinese Population.

Journal: Research (Washington, D.C.)

Published: July 19, 2025

Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classification.

Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classification.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 04, 2025

CircRNA SLAIN1 is associated with reduced malignancy progression of glioblastoma and the M2-like polarization of tumor-associated macrophages via miR-1225-3p/NLRX1 axis.

CircRNA SLAIN1 is associated with reduced malignancy progression of glioblastoma and the M2-like polarization of tumor-associated macrophages via miR-1225-3p/NLRX1 axis.

Journal: International journal of biological macromolecules

Published: April 16, 2025

GSCs differentiation model-informed nanotherapy: dual-functional brain-targeting liposomes with iRGD modification for co-delivery of osimertinib and bortezomib to combat radioresistant glioblastoma.

GSCs differentiation model-informed nanotherapy: dual-functional brain-targeting liposomes with iRGD modification for co-delivery of osimertinib and bortezomib to combat radioresistant glioblastoma.

Journal: Cell death & disease

Published: April 15, 2025

A Study on Rare Earth-Modified Co-Based Composite Powder and Its Effects on the Microstructure and Properties of Cemented Carbide.

A Study on Rare Earth-Modified Co-Based Composite Powder and Its Effects on the Microstructure and Properties of Cemented Carbide.

Journal: Materials (Basel, Switzerland)

Published: February 26, 2025

Large-scale bulk and single-cell RNA sequencing combined with machine learning reveals glioblastoma-associated neutrophil heterogeneity and establishes a VEGFA+ neutrophil prognostic model.

Large-scale bulk and single-cell RNA sequencing combined with machine learning reveals glioblastoma-associated neutrophil heterogeneity and establishes a VEGFA+ neutrophil prognostic model.

Journal: Biology direct

Published: December 26, 2024

Predicting progression of enhancing non-measurable disease in high-grade glioma by using dynamic contrast-enhanced MR imaging.

Predicting progression of enhancing non-measurable disease in high-grade glioma by using dynamic contrast-enhanced MR imaging.

Journal: Magnetic resonance imaging

Published: July 10, 2024

Single-cell multi-omics analysis reveals candidate therapeutic drugs and key transcription factor specifically for the mesenchymal subtype of glioblastoma.

Single-cell multi-omics analysis reveals candidate therapeutic drugs and key transcription factor specifically for the mesenchymal subtype of glioblastoma.

Journal: Cell & bioscience

Published: July 10, 2024

Stimuli-Responsive Peptide/siRNA Nanoparticles as a Radiation Sensitizer for Glioblastoma Treatment by Co-Inhibiting RELA/P65 and EGFR.

Stimuli-Responsive Peptide/siRNA Nanoparticles as a Radiation Sensitizer for Glioblastoma Treatment by Co-Inhibiting RELA/P65 and EGFR.

Journal: International journal of nanomedicine

Published: June 18, 2024

Targeting ferroptosis in cancer stem cells: A novel strategy to improve cancer treatment.

Targeting ferroptosis in cancer stem cells: A novel strategy to improve cancer treatment.

Journal: Genes & diseases

Published: April 18, 2024

Correction: albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis.

Correction: albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 24, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026